375 related articles for article (PubMed ID: 21179119)
1. Experimental human challenge infections can accelerate clinical malaria vaccine development.
Sauerwein RW; Roestenberg M; Moorthy VS
Nat Rev Immunol; 2011 Jan; 11(1):57-64. PubMed ID: 21179119
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus vectors expressing Plasmodium knowlesi antigens induce immune responses that delay parasitemia upon sporozoite challenge.
Hansen SG; Womack J; Scholz I; Renner A; Edgel KA; Xu G; Ford JC; Grey M; St Laurent B; Turner JM; Planer S; Legasse AW; Richie TL; Aguiar JC; Axthelm MK; Villasante ED; Weiss W; Edlefsen PT; Picker LJ; Früh K
PLoS One; 2019; 14(1):e0210252. PubMed ID: 30673723
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy.
Leitner WW; Bergmann-Leitner ES; Angov E
Malar J; 2010 May; 9():145. PubMed ID: 20507620
[TBL] [Abstract][Full Text] [Related]
4. Strain-specific protective effect of the immunity induced by live malarial sporozoites under chloroquine cover.
Wijayalath W; Cheesman S; Tanabe K; Handunnetti S; Carter R; Pathirana S
PLoS One; 2012; 7(9):e45861. PubMed ID: 23029282
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of preerythrocytic and blood-stage malaria vaccines can be assessed in small sporozoite challenge trials in human volunteers.
Roestenberg M; de Vlas SJ; Nieman AE; Sauerwein RW; Hermsen CC
J Infect Dis; 2012 Aug; 206(3):319-23. PubMed ID: 22615322
[TBL] [Abstract][Full Text] [Related]
6. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens.
Bettencourt P
Front Immunol; 2020; 11():190. PubMed ID: 32153565
[No Abstract] [Full Text] [Related]
7. Novel approaches to whole sporozoite vaccination against malaria.
Bijker EM; Borrmann S; Kappe SH; Mordmüller B; Sack BK; Khan SM
Vaccine; 2015 Dec; 33(52):7462-8. PubMed ID: 26469716
[TBL] [Abstract][Full Text] [Related]
8. Down-selecting circumsporozoite protein-based malaria vaccine: A comparison of malaria sporozoite challenge model.
Amelia F; Iyori M; Emran TB; Yamamoto DS; Genshi K; Otsuka H; Onoue Y; Yusuf Y; Islam A; Yoshida S
Parasite Immunol; 2019 May; 41(5):e12624. PubMed ID: 30883819
[TBL] [Abstract][Full Text] [Related]
9. Preerythrocytic malaria vaccine development.
Mikolajczak SA; Aly AS; Kappe SH
Curr Opin Infect Dis; 2007 Oct; 20(5):461-6. PubMed ID: 17762778
[TBL] [Abstract][Full Text] [Related]
10. A Plasmodium vivax Plasmid DNA- and Adenovirus-Vectored Malaria Vaccine Encoding Blood-Stage Antigens AMA1 and MSP1
Obaldia N; Stockelman MG; Otero W; Cockrill JA; Ganeshan H; Abot EN; Zhang J; Limbach K; Charoenvit Y; Doolan DL; Tang DC; Richie TL
Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28179404
[TBL] [Abstract][Full Text] [Related]
11. Genetically attenuated malaria parasites as vaccines.
Vaughan AM; Kappe SHI
Expert Rev Vaccines; 2017 Aug; 16(8):765-767. PubMed ID: 28612631
[No Abstract] [Full Text] [Related]
12.
Nevagi RJ; Good MF; Stanisic DI
Expert Rev Vaccines; 2021 Feb; 20(2):163-183. PubMed ID: 33428505
[No Abstract] [Full Text] [Related]
13. Designer Parasites: Genetically Engineered
Goswami D; Minkah NK; Kappe SHI
J Immunol; 2019 Jan; 202(1):20-28. PubMed ID: 30587570
[TBL] [Abstract][Full Text] [Related]
14. Asexual blood-stage malaria vaccine development: facing the challenges.
Genton B; Reed ZH
Curr Opin Infect Dis; 2007 Oct; 20(5):467-75. PubMed ID: 17762779
[TBL] [Abstract][Full Text] [Related]
15. Targeting Plasmodium liver stages: better late than never.
Borrmann S; Matuschewski K
Trends Mol Med; 2011 Sep; 17(9):527-36. PubMed ID: 21737347
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite.
Friesen J; Matuschewski K
Vaccine; 2011 Sep; 29(40):7002-8. PubMed ID: 21787828
[TBL] [Abstract][Full Text] [Related]
17. Mosquito stage, transmission blocking vaccines for malaria.
Saul A
Curr Opin Infect Dis; 2007 Oct; 20(5):476-81. PubMed ID: 17762780
[TBL] [Abstract][Full Text] [Related]
18. Malaria vaccine: a bright prospect for elimination of malaria.
Bairwa M; Rajput M; Khanna P; Rohilla R; Verma R; Chawla S
Hum Vaccin Immunother; 2012 Jun; 8(6):819-22. PubMed ID: 22739688
[TBL] [Abstract][Full Text] [Related]
19. Reflections on early malaria vaccine studies, the first successful human malaria vaccination, and beyond.
Vanderberg JP
Vaccine; 2009 Jan; 27(1):2-9. PubMed ID: 18973784
[TBL] [Abstract][Full Text] [Related]
20. Designing malaria vaccines to circumvent antigen variability.
Ouattara A; Barry AE; Dutta S; Remarque EJ; Beeson JG; Plowe CV
Vaccine; 2015 Dec; 33(52):7506-12. PubMed ID: 26475447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
